Top Track 250

The late Sir Allen McClay established this pharmaceuticals developer in 2001, and it has grown to provide research, development and commercialisation services to more than 600 international biopharma companies. Based in Co Armagh, Northern Ireland, it has offices in America, Singapore and Japan, and last year announced a £31m investment plan to expand operations in Europe and North America. Alan Armstrong, 58, is chairman and chief executive.

This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.

Company details
ActivityPharmaceuticals manufacturer
LocationCo Armagh
Sales £m447.2
Operating profit £m27.1
Main shareholdersMcClay Foundation (100%)

If applicable:

* supplied by company   † annualised figure   ‡  profit = ebitda